Package 50242-132-01

{"route": ["INTRAVENOUS"], "spl_id": "5e75840c-4462-440a-9e17-caa80dd4127b", "openfda": {"nui": ["N0000175661", "N0000020008"], "unii": ["P188ANX8CK"], "rxcui": ["1922509", "1922512"], "spl_set_id": ["492dbdb2-077e-4064-bff3-372d6af0a7a2"], "pharm_class_epc": ["HER2/neu Receptor Antagonist [EPC]"], "pharm_class_moa": ["HER2/Neu/cerbB2 Antagonists [MoA]"], "manufacturer_name": ["Genentech, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (50242-132-01)  / 15 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "50242-132-01", "marketing_start_date": "20170210"}], "brand_name": "Herceptin", "product_id": "50242-132_5e75840c-4462-440a-9e17-caa80dd4127b", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["HER2/Neu/cerbB2 Antagonists [MoA]", "HER2/neu Receptor Antagonist [EPC]"], "product_ndc": "50242-132", "generic_name": "Trastuzumab", "labeler_name": "Genentech, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Herceptin", "active_ingredients": [{"name": "TRASTUZUMAB", "strength": "150 mg/7.4mL"}], "application_number": "BLA103792", "marketing_category": "BLA", "marketing_start_date": "20170210", "listing_expiration_date": "20261231"}